Shaked, Sigal, Lior Rokach, Ronen Arbel, Talish Razi, and Tamar Tadmor. 2026. “Glucagon-Like Peptide-1 Receptor Agonist Exposure Is Associated With Lower Secondary Malignancy Risk During Watch-and-Wait in Chronic Lymphocytic Leukemia: A Timevarying Analysis”. Haematologica, November. Pavia, Italy. https://doi.org/10.3324/haematol.2026.301905.